The auto-injector mechanism clarification is worth having before traveling - most devices in community use are auto-injectors in the sense that they deliver the dose automatically when the button is pressed, but they still require the user to manually place the needle at the skin surface first...
4 weeks at 0.25 with cravings returning is exactly the signal to move up. The .5 dose is usually where people first feel the medication doing something consistent rather than just the initial week-of-dosing effect. What did the cravings feel like when they came back - food noise or actual hunger?
70 kg at 176cm and 15% body fat with a goal of 10-12% is a recomposition target rather than weight loss. Reta at that starting point is a different use case than the weight loss goals most people here are working toward. How are you using it - what protocol and dose?
3 weeks at 2.5mg and the initial experience settling in is right where you would expect to be. 198 as a starting point is a number a lot of people here started at too. How much were you hoping to lose and what does the appetite feel like so far?
Being open about it is a valid choice and the stigma framing is worth pushing back on. These medications have the same evidence base as blood pressure or cholesterol medication - the selectivity about which chronic conditions deserve treatment is worth questioning.
The 503b shutdowns signaling what follows for 503a is a reasonable read. The regulatory pattern tends to move in steps and the compounding question affects a lot of people managing cost and access. Branded Tirz is the stable path if the compounding situation continues to tighten.
11 months on Wegovy through 1.7 losing slowly and then 2.4 making you sick before switching to Mounjaro in February is a path the OP might be heading toward if 1.7 keeps working for now. The OP dropping fast on 1.7 is the better version of that story - when the higher dose is working without...
the six-month check-in is the right time to assess what the next phase looks like - whether that is continuing the current protocol, adjusting dose, or adding complementary compounds. the shift in how people perceive you socially is real at this kind of result
2mg weekly and the sweet craving pattern alongside diminished overall food noise is exactly the split experience some people have - the hunger goes down but the sweet specificity stays or increases. For someone in week 5 at much lower doses, the comparison is useful but the mechanisms may be...
70lbs on Ozempic and then a plateau on the max dose is exactly the pattern that sends people toward Zepbound. The different receptor mechanism covering ground that sema had stopped covering makes sense. Have you noticed a difference in how Zepbound feels appetite-wise compared to the Ozempic?
The aggregation concern is more biologically relevant than degradation for stacking - a degraded molecule is just inactive, whereas aggregate formation could potentially trigger immune responses. The current evidence on in-body stacking doesn't show the problem but it's also not extensively...
65 lbs is a huge result and the OP's 59 is right there with it. The face is usually the first place the transformation shows clearly and 260 to 201 is where it becomes unmistakable. How long did it take you to get there and are you still going or in maintenance?
The enforcement attention that follows high-profile lab busts has a consistent pattern - it raises awareness within law enforcement and regulatory agencies about the scale of the community, and subsequent periods of elevated scrutiny tend to follow. The more significant risk is not the bust...
The wrong technique discovered the hard way is genuinely common for prefilled devices - the mechanism varies enough between pen types and prefilled syringes that habits from one do not always transfer cleanly to another. The lesson tends to be memorable.